Yes, these look like good acquisitions, probably a much better option than paying a dividend. One more good year and you'd think Konekt would have to be worth more like $40 million than 20.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
